Anti-VEGF Therapy: Basics and Substances

S. Grisanti; J. Lüke; S. Peters

doi:10.1007/978-3-642-22107-1_14

Anti-VEGF Therapy: Basics and Substances

S. Grisanti^*, J. Lüke, S. Peters

^*Corresponding author for this work

2 Citations (Scopus)

Abstract

VEGF refers to several factors and isoforms that bind to distinguished receptors, which initiate different pathways and modulate a multitude of complex mechanisms including neovascularization.

Original language	English
Title of host publication	Age-Related Macular Degeneration
Number of pages	7
Publisher	Springer Berlin Heidelberg
Publication date	01.01.2013
Pages	225-231
ISBN (Print)	9783642221064
ISBN (Electronic)	9783642221071
DOIs	https://doi.org/10.1007/978-3-642-22107-1_14
Publication status	Published - 01.01.2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-642-22107-1_14

Cite this

@inbook{509d214e8ed8469f8d9ffc690da1f2ab,

title = "Anti-VEGF Therapy: Basics and Substances",

abstract = "VEGF refers to several factors and isoforms that bind to distinguished receptors, which initiate different pathways and modulate a multitude of complex mechanisms including neovascularization.",

author = "S. Grisanti and J. L{\"u}ke and S. Peters",

year = "2013",

month = jan,

day = "1",

doi = "10.1007/978-3-642-22107-1_14",

language = "English",

isbn = "9783642221064",

pages = "225--231",

booktitle = "Age-Related Macular Degeneration",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Anti-VEGF Therapy

T2 - Basics and Substances

AU - Grisanti, S.

AU - Lüke, J.

AU - Peters, S.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - VEGF refers to several factors and isoforms that bind to distinguished receptors, which initiate different pathways and modulate a multitude of complex mechanisms including neovascularization.

AB - VEGF refers to several factors and isoforms that bind to distinguished receptors, which initiate different pathways and modulate a multitude of complex mechanisms including neovascularization.

UR - http://www.scopus.com/inward/record.url?scp=84897511342&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-22107-1_14

DO - 10.1007/978-3-642-22107-1_14

M3 - Chapter

AN - SCOPUS:84897511342

SN - 9783642221064

SP - 225

EP - 231

BT - Age-Related Macular Degeneration

PB - Springer Berlin Heidelberg

ER -

Anti-VEGF Therapy: Basics and Substances

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this